Is Accretion Pharmaceuticals Ltd debt-free?

No, Accretion Pharmaceuticals Ltd is not debt-free with a debt-to-equity ratio of 0.92.

Home

Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals Ltd Financials

Accretion Pharmaceuticals Ltd Financial Statement

Accretion Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Accretion Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024
Total Revenue Annual	13.35
Operating Expenses Annual	10.72
Operating Profit Annual	2.69
Interest Annual	0.47
Depreciation	0.22
Net Profit Annual	1.49
Tax Annual	0.50

Particulars	Mar 2024
Total Revenue Annual	13.35
Operating Expenses Annual	10.72
Operating Profit Annual	2.69
Interest Annual	0.47
Depreciation	0.22
Net Profit Annual	1.49
Tax Annual	0.50

Accretion Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024
Cash Flow at the Beginning	TBA
Cash Flow from Operations	-11.44
Cash Flow from Investing	-5.48
Cash Flow from Financing	17.01
Cash Flow at the End	0.09

Particulars	Mar 2024
Cash Flow at the Beginning	TBA
Cash Flow from Operations	-11.44
Cash Flow from Investing	-5.48
Cash Flow from Financing	17.01
Cash Flow at the End	0.09

Accretion Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024
PBDIT Margin (%)	20.15
PBIT Margin (%)	18.50
PBT Margin (%)	-20.68
Net PROFIT Margin (%)	11.16
Return On Networth / Equity (%)	65.14
Return On Networth /Employed (%)	31.12
Return On Assets (%)	18.86
Total Debt / Equity (X)	2.46
Asset Turnover Ratio (%)	1.69

Particulars	Mar 2024
PBDIT Margin (%)	20.15
PBIT Margin (%)	18.50
PBT Margin (%)	-20.68
Net PROFIT Margin (%)	11.16
Return On Networth / Equity (%)	65.14
Return On Networth /Employed (%)	31.12
Return On Assets (%)	18.86
Total Debt / Equity (X)	2.46
Asset Turnover Ratio (%)	1.69

Accretion Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024
Fixed Assets Annual	5.25
Total Current Assets Annual	21.48
Non Current Assets Annual	5.39
Total Shareholders Funds Annual	5.49
Total Assets Annual	26.87

Particulars	Mar 2024
Fixed Assets Annual	5.25
Total Current Assets Annual	21.48
Non Current Assets Annual	5.39
Total Shareholders Funds Annual	5.49
Total Assets Annual	26.87

Accretion Pharmaceuticals Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Accretion Pharmaceuticals Ltd Financials

As of Sep 3, 2025, Accretion Pharmaceuticals Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Accretion Pharmaceuticals Ltd is not with a debt-to-equity ratio of 0.92.

In FY 2024 , Accretion Pharmaceuticals Ltd recorded a total revenue of approximately 57.38 Cr marking a significant milestone in the company's financial performance.

Accretion Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.3% annually, respectively..

Accretion Pharmaceuticals Ltd's current PE ratio is .

Accretion Pharmaceuticals Ltd's ROCE averaged 20.2% from the FY ending March 2023 to 2025, with a median of 12.6%. It peaked at 38.1% in March 2025, reflecting strong capital efficiency over the period..

Accretion Pharmaceuticals Ltd's latest EBIT is Rs. 11.20 Cr, surpassing the average EBIT of Rs. 4.94 Cr over the 5 years..